«We found particular association between Lin28 and high - risk «blastemal» Wilms tumors,» says Daley,
director of the Stem Cell Transplantation Program at Boston Children's and an investigator with the Howard Hughes Medical Institute.
«To date, there has been no systematic means of assessing the fidelity of cellular engineering — to determine how closely cells made in a petri dish approximate natural tissues in the body,» says George Q. Daley, MD, PhD, Director
of the Stem Cell Transplantation Program at Boston Children's and senior investigator on both studies.
The Pediatric
Division of Stem Cell Transplantation and Regenerative Medicine is very proud of the outstanding compassionate care that we provide our patients along with conducting state of the art basic and translational science on stem cell biology, cellular immunology and transplantation biology.
An update search enlarged the pool of study data, but did not change the content of the conclusion of the benefit
assessment of stem cell transplantation (SCT) for multiple myeloma conducted in 2012.
The technology to grow NK cells from umbilical cord blood was developed by Nina Shah, M.D., assistant professor and Elizabeth J. Shpall, M.D., professor in the
department of Stem Cell Transplantation and Cellular Therapy at The University of Texas MD Anderson Cancer Center.
We're partnering with the Adoptive Cellular Therapy and ORBIT Moon Shot ™ platforms to develop safe and effective cellular therapies that can be used to treat MDS and AML and improve the clinical
outcomes of stem cell transplantation (SCT).
While there's growing interest in the
use of stem cell transplantation for treating type 2 diabetes, not much research has looked at the use of stem cells derived from bone marrow.
Ogawa - Yamanaka Prize committee members include George Daley, PhD (professor of hematology / oncology and
director of the Stem Cell Transplantation Program at Boston's Children Hospital), Hideyuki Okano, MD, PhD (chairman of Keio University Graduate School of Medicine), Shinya Yamanaka, MD, PhD (senior investigator at the Gladstone Institutes and director of the Center for iPS Cell Research and Application, Kyoto University), Srivastava, and Wernig.
Executive Director — Stem Cells and Cellular Therapeutics Operations, Stanford University School of Medicine, USADr David DiGiusto is the Executive Director of Stem Cell and Cellular Therapeutic Operations for Stanford Hospital and Clinics and a Senior Academic Researcher in the
Division of Stem Cell Transplantation and Regenerative Medicine at Stanford University.